|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 27, 519-524, Copyright © 1986 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
M Wiederholt, D Kossendrup, W Schulz and F Hoffmann
3H labelled cyclosporin A (CS-A) eye drops (2% in castor oil) were applied in rabbits. When a single drop of 10 microliters was given CS-A reached a maximal concentration of 900-1400 ng/ml in the cornea 6 hr after application and then slowly decreased. A substantial level of 600- 900 ng/ml was still present after 48 hr. When corneas were analysed for their cellular compartments, 67% of CS-A was found in the epithelium, 25% in the stroma (probably in keratocytes), and 8% in the endothelium. In corneas denervated by circular keratotomy, slightly reduced concentrations were found after surgery, the reduction was not therapeutically significant. Using the HPLC method a significant corneal metabolism of CS-A could be excluded. Scleral concentrations of CS-A as high as 180 ng/ml were found. Concentrations of CS-A in aqueous humor, lens, vitreous body and uvea/retina were below the therapeutic range.
This article has been cited by other articles:
![]() |
T. Said, M. Dutot, R. Christon, J.-L. Beaudeux, C. Martin, J.-M. Warnet, and P. Rat Benefits and Side Effects of Different Vegetable Oil Vectors on Apoptosis, Oxidative Stress, and P2X7 Cell Death Receptor Activation Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5000 - 5006. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leonardi, G. DeFranchis, I. A. Fregona, D. Violato, M. Plebani, and A. G. Secchi Effects of Cyclosporin A on Human Conjunctival Fibroblasts Arch Ophthalmol, October 1, 2001; 119(10): 1512 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawazu, K. Yamada, M. Nakamura, and A. Ota Characterization of Cyclosporin A Transport in Cultured Rabbit Corneal Epithelial Cells: P-Glycoprotein Transport Activity and Binding to Cyclophilin Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1738 - 1744. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |